Dr. Reddy's launchesgeneric Revlimid capsules in the US
Earlier, Celgene agreed to provide Dr. Reddy's a licence to sell volume-limitedamounts of generic lenalidomide capsules in the US in settlement of all outstanding claims of itslitigation DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr. Reddy''s Laboratories announces the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market, 180-day exclusivity. DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings DR.REDDY'S LABORATORIES LTD. - 500124 - Dr Reddys Laboratories Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing on https://www.thehindubusinessline.com/companies/dr-reddys-aurigene-ink-mou-with-dndi-on-neglected-tropical-diseases/article65830732.ece (Source: https://www.thehindubusinessline.com) dated August 30, 2022 titled "Dr Reddys, Aurigene ink MoU with DNDi on neglected tropical diseases'.Dr Reddys Laboratories Ltd response is enclosed. DR.REDDY'S LABORATORIES LTD. - 500124 - Clarification sought from Dr Reddys Laboratories Ltd
The Exchange has sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing on https://www.thehindubusinessline.com/companies/dr-reddys-aurigene-ink-mou-with-dndi-on-neglected-tropical-diseases/article65830732.ece (Source: https://www.thehindubusinessline.com) dated August 30, 2022 titled "Dr Reddys, Aurigene ink MoU with DNDi on neglected tropical diseases'.The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the Listing Regulations, 2015. Dr Reddy's, Aurigene ink MoU with DNDi on neglected tropical diseases
Neglected tropical diseases are a diverse group of 20 conditions that are mainly prevalent in tropical areas
Stocks to Watch Today | Dr Reddy's Laboratories, Syrma SGS Technology, Eicher Motors, and others in news today
Stocks to Watch: Check out the companies making headlines before the opening bell. 